Replies to post #22480 on Cytogenix (fka CYGX)

[bigworld]

Paulness: Indeed, Alfa Laval is a heavy hitter in the industry niche where they operate. CYGX could not be in better hands to design and build a world class synDNA manufacturing facility. I expect it to be on-line and fully operational by the end of 2007. And the prototype module will be sufficient to make testable quantities and small batches within a much shorter time frame, perhaps by year end. All we need is Aldevron's confirmation of synDNA effectiveness in vaccines. I hope that happens before the big Vaccine conference in November. Is so, the vaccine manufacturers will be lined up to purchase or license synDNA. Maybe 2005 will be our big breakout year. We still have a little over 4 months to go. And I'm seeing money pouring into small fry biotech again. Look at what happened with CVM today.